Bank of America
SBFM

Bank of America’s Sunshine Biopharma SBFM Stock Holding History

Bank of America’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$6 – 6692
2025
Q4 		$6 Hold
1
– – ﹤0.01% 7222
2025
Q3 		$7 Hold
1
– – ﹤0.01% 8235
2025
Q2 		$7 Hold
1
– – ﹤0.01% 8311
2025
Q1 		$10 Hold
1
– – ﹤0.01% 8212
2024
Q4 		$15 Sell
1
-3,447
-100% -$98.1K ﹤0.01% 8061
2024
Q3 		$110K Buy
3,448
+3,447
+344,700% +$147K ﹤0.01% 6290
2024
Q2 		$42 Hold
1
– – ﹤0.01% 7871
2024
Q1 		$600 Hold
1
– – ﹤0.01% 7260
2023
Q4 		$2.71K Buy
+1
New +$5.69K ﹤0.01% 7094
2023
Q1 		– Sell
-1
Closed -$8.88K – 8214
2022
Q4 		$8.88K Hold
1
– – ﹤0.01% 6942
2022
Q3 		$13K Buy
+1
New +$21.7K ﹤0.01% 7168
2022
Q2 		– Hold
0
– – – 7655

Other funds holding SBFM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Bank of America's SBFM Position: Q1 2026 in Review

Bank of America sold out of Sunshine Biopharma (SBFM) in Q1 2026, closing a stake of 1 share — an estimated $6 sold.

Bank of America first reported a position in SBFM in Q3 2022 and held it in 11 quarters. The position peaked at $110K in Q3 2024. 8 funds tracked by Wall St. Rank hold SBFM as of Q1 2026.

  • Bank of America reported no remaining Sunshine Biopharma position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1 Sunshine Biopharma share in Q1 2026, an estimated $6.
  • Bank of America first reported a position in Sunshine Biopharma in Q3 2022 and held it in 11 quarters.
  • Bank of America's Sunshine Biopharma position peaked at $110K in Q3 2024.
  • 8 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.